SuperworthPalvella Therapeutics shares outstanding PVLA
Diluted shares outstanding, averaged over each quarter, from 2013.
- Latest quarter, to Jun 30, 2026
- 14.4M
- On a year earlier
- +29.9%
- more shares
Palvella Therapeutics had 14.4M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 29.9% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 11.9M | +231% |
| FY2024 | 3.6M | +298% |
| FY2021 | 900.6K | +29% |
| FY2020 | 699.8K | +6% |
| FY2019 | 663.2K | −2% |
| FY2018 | 676.9K | +21% |
| FY2017 | 560.5K | +4% |
| FY2016 | 538.3K | +8% |
| FY2015 | 497K | +236% |
| FY2014 | 147.9K | −41% |
| FY2014 | 249.2K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 14.4M | +30% | |
| Q1 FY26 | 13.1M | +19% | |
| Q4 FY25 | 11.9M | +231% | |
| Q3 FY25 | 11.1M | +525% | |
| Q2 FY25 | 11.1M | +524% | |
| Q1 FY25 | 11M | +522% | |
| Q4 FY24 | 3.6M | n/a | |
| Q3 FY24 | 1.8M | +43% | |
| Q2 FY24 | 1.8M | +61% | |
| Q1 FY24 | 1.8M | n/a | |
| Q3 FY23 | 1.2M | n/a | |
| Q2 FY23 | 1.1M | +19% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Palvella Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.